Blog

THE FEHV: The  Foundation for the Study of Viral Hepatitis is a  leading international non-profit organization in the field of hepatology , with  top specialists  in  liver diseases  and molecular biology. At our clinic in Madrid, we treat… Read more: Fatty Liver and Hepatitis B

EASL has come and gone for the year and this article is a stellar summary: From EASL 2026: “What Hepatology Still Needs to Solve.” The AJMC article highlights a panel… Read more: EASL 2026 Summary

The article, “A therapeutic turning point in metabolic liver disease” (npj Gut and Liver, June 2026), is an editorial that argues the field of metabolic liver disease has entered a… Read more: Turning Point in Liver Disease

We will miss Tony Villiotti’s peerless innovation in moving liver disease in America from very low awareness among patients, payers and providers, to its current state of surging enthusiasm, energy… Read more: Pillar of Liver Disease Awareness: Tony Villiotti

The 05/26/2026 article “The importance of reading your medical records when living with MASH” from Liver Disease News powered by Bionews highlights how reading your own medical records can be… Read more: MASH and your Medical Records

Roche announced a new “Liver Disease Panel,” which it says is the first certified suite of digital algorithms designed to help clinicians detect and manage chronic liver disease (CLD) earlier… Read more: New Liver Disease Panel from Roche

This May 26, 2026 article cleverly titled “From Margin to Mainstream: Why Liver Health Should Sit at the Centre of the Global NCD Response” by Jeffrey Lazarus in Health Policy… Read more: Liver Disease Mainstream

It’s a complex organ– 1. Your liver can regenerate itselfIt’s the only internal organ that can regrow lost tissue. Even if up to about 70% is removed, it can regenerate… Read more: Meet the Human Liver

Big Gilead news: “FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)“. Gilead announced that the FDA has granted… Read more: HEPCLUDEX Approval

The article titled “Hepatitis C Treatment Could Save Billions” explains that expanding access to HCV treatment—especially among Medicaid patients—could generate major long-term healthcare savings while dramatically improving patient outcomes. Key… Read more: HCV Treatment Savings

This May 16, 2026 Cureus review titled “Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Diagnostic Pathways, Noninvasive Fibrosis Assessment, and Therapeutic Strategies” is essentially a “state of the field” overview of… Read more: State of MASLD

The Liver Disease News article “Steatotic liver disease and diet: Foods to eat and avoid” of March 4, 2026, by Marisa Wexler, MS has news you can use. Key Takeaways… Read more: Liver Disease and Diet

Summary: Acute Liver Failure: 5 Things to Know By Eugenia Tsai, MD (May 8, 2026), and here’s the URL of the article on Medscape: This article reviews the key clinical… Read more: Acute Liver Failure

This paper titled “Organ failure-based clinical classification at onset of acute-on-chronic liver failure: a prospective multicenter cohort study” from Scientific Reports proposes a new way to classify acute-on-chronic liver failure… Read more: ACLF Classification Reconsidered

The article by Elliott Tapper, MD entitled “The Changing Face of Cirrhosis” is a must read. It was published April 15, 2026 in docwirenews. Summary- 🔑 The Core Shift Cirrhosis… Read more: Cirrhosis Shift

LiverRight’s David Sires and Kevin Harlen are at DDW in Chicago. Digestive Disease Week® (DDW) 2026 takes place in Chicago, IL, from May 2–5, 2026, offering a premier forum for GI… Read more: DDW 2026

Summary of the article from Pitchbook titled “PitchBook Analyst Note: AI Will Deliver Care to Billions and Break the System That Built It.” 🧠 Core thesis AI will massively expand… Read more: AI and the Healthcare Effect

Enlightening article from Roll Call: “Deadly liver disease, rooted out elsewhere, retains grip on US“. Summary: Bottom line The article argues that the U.S. has the tools to eliminate hepatitis… Read more: Hepatitis C in America Today

As of 2026, there are ~1,359 FQHC (Federally Qualified Health Center) organizations in the United States, operating more than 16,300 service delivery sites. These sites are located across all 50… Read more: Hello, FQHCs

Great article here- Timely hepatitis C screening helps US patients avoid costly illness (Investing in early treatment saves thousands in healthcare expenses over time) from April 23, 2026 in Liver… Read more: HCV Testing Drives Savings

Liver needs one of these: HHS Announces $4 Million KidneyX EMPOWER Prize Challenge and Health Technology Project to Advance Living Kidney Donation and Patient-Centered Innovation. Key quote: The $4 million… Read more: Hello, KidneyX

Most liver disease is preventable. April 19, 2026 is World Liver Day. From the site https://worldliverday.org/ — Solid Habits, Strong Liver. Your liver is a powerhouse:  it filters blood, breaks… Read more: World Liver Day

Lisa Norris is the Managing Director & Principal at Transplant Leadership Institute LLC, and a veteran Transplant Services Director. This is her superb book relating to the $11 billion in… Read more: Transplant Administration Explained

Liver disease can turn into liver cancer through a gradual, multi-step process driven by chronic damage, inflammation, and cell mutation. Here’s the clearest way to understand it: 1. Chronic liver… Read more: How Liver Disease Can Become Liver Cancer

The JAMA Network Open article of 01/26/2026 titled “Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs” is revelatory– 🧠 Study Overview 🔑 Key Findings 💡… Read more: Mobile Telemedicine for Treating Hepatitis

The article “8 takeaways about MASH, an increasingly common liver disease associated with obesity” from Managed Care Executive dated April 7, 2026, has a cogent analysis on MASLD/MASH. Summarized– 8… Read more: MASH Explainer

Here we summarize “Association between metabolic dysfunction-associated steatotic liver disease and obstructive sleep apnea: a nationwide retrospective cohort study” from Scientific Reports (Nature Portfolio), March 2026. 🎯 Objective The study… Read more: OSA and Liver Disease